Yu X, Munoz-Sagredo L, Streule K, Muschong P, et al. CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues. Blood 2021;138:1067-1080.
PMID: 34115113